| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Manufacturing Capacity as a Commodity |
|
Digg It - Manufacturing Capacity as a Commodity
Excess capacity in an automobile plant at Ford, Chrysler, Toyota, GM, and Honda is a comm According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product odity and those who study finite capacity scheduling modules can readily see the possibil ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ties for increased production and that means profit. Einstein said time is relative, that lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. is true, time is relative, manipulating commodity theoretical models allows companies to here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe see thru time and keep costs and purchases on an even keel without the problems of relati d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e time. Thus the commodity can be simplified to price/cost models. The commodity is still ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc relative to fluctuations in currency, weather, and supply and demand. There is no reason easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi a company like Ford cannot take those plants, which have closed and use them to make some nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically hing else. Instead, they ran their plants at maximum capacity or close to it, and built l and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ts of cars, which are now in the dealers or on their way to the dealers and there is no n ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ed to run the plants now sense there are enough cars built. If the cars become scarce, th ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a en the price goes up. As with anything; supply and demand. Are cars a commodity? It appea dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod s they are, but more so the time in the excess capacity in the factories is the real comm cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin dity although from a purely conceptual standpoint, both the time and the cars are commodi tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ties. Excess capacity also occurs in many other industries, such as electricity, water, t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel il, mainframe time, bandwidth, etc. When deregulation came to the California energy marke ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust we saw an interesting thing occur. People would buy blocks of kilowatt-hours from the ex y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products isting energy companies who made electricity. They had to make this available to anyone. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de o entrepreneurs Bought lots of it and then they sold it to others wishing to buy it. Comm elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip dity theory is fun to study, because it is everywhere in our civilization, think about it tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:4 Great Tips to Selecting a Marketing or Advertising Agency Tracking Time Was Never So Easy Performance Management - Before Implementing a System
|